Sapacitabine (CS-682)
Revision as of 21:24, 4 July 2023 by Warner-admin (talk | contribs) (Text replacement - "(NCT[0-9]{8}) Clinical Trials Registry" to "$1 $1")
Mechanism of action
Pyrimidine analogue
Preliminary results
Acute myeloid leukemia
- CYC682-06: Kantarjian H, Faderl S, Garcia-Manero G, Luger S, Venugopal P, Maness L, Wetzler M, Coutre S, Stock W, Claxton D, Goldberg SL, Arellano M, Strickland SA, Seiter K, Schiller G, Jabbour E, Chiao J, Plunkett W. Oral sapacitabine for the treatment of acute myeloid leukaemia in elderly patients: a randomised phase 2 study. Lancet Oncol. 2012 Nov;13(11):1096-104. Epub 2012 Oct 15. link to original article link to PMC article PubMed NCT00590187
Also known as
- Code name: CS-682